Mae degawdau o gydweithio a chysoni safonau ar feddyginiaethau a thechnolegau meddygol wedi arwain at fanteision amlwg i ddinasyddion yr Undeb Ewropeaidd. Byddai unrhyw gyfyngiadau ar fasnach, gwiriadau tollau a thariffau masnach yn debyg o effeithio ar y meddyginiaethau sydd ar gael, gan arwain o bosib at oedi mewn cyflenwadau o gyffuriau a brechlynnau a chostau uwch i'r Gwasanaeth Iechyd Gwladol yng Nghymru.”
Decades of cooperation and harmonisation of standards on medicines and medical technologies have produced proven benefits for EU citizens. Any restrictions on trade, customs checks and trade tariffs are likely to reduce the availability of medicines, lead to delays in the supply of drugs and vaccines and potentially increased costs to the NHS in Wales.”